Inventiva SA
F:6IV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Inventiva SA
F:6IV
|
FR |
|
Tamburi Investment Partners SpA
MIL:TIP
|
IT |
|
A
|
Adani Ports and Special Economic Zone Ltd
BSE:532921
|
IN |
|
B
|
BHG Group AB
F:7B1
|
SE |
|
K
|
KGHM Polska Miedz SA
XMUN:KGHA
|
PL |
|
A
|
ACADIA Pharmaceuticals Inc
F:DR6
|
US |
|
P
|
Puma SE
OTC:PUMSY
|
DE |
|
SPAR Group Ltd
OTC:SGPPF
|
ZA |
|
ASR Nederland NV
F:A16
|
NL |
|
Teva Pharmaceutical Industries Ltd
F:TEV
|
IL |
|
DEME Group NV
XBRU:DEME
|
BE |
Wall St Price Targets
6IV Price Targets Summary
Inventiva SA
According to Wall Street analysts, the average 1-year price target for
6IV is 12.96 EUR with a low forecast of 7.32 EUR and a high forecast of 24.26 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 6IV's stock price target?
Price Target
12.96
EUR
According to Wall Street analysts, the average 1-year price target for
6IV is 12.96 EUR with a low forecast of 7.32 EUR and a high forecast of 24.26 EUR.
What is the Revenue forecast for Inventiva SA?
Projected CAGR
197%
Over the last 11 years, the compound annual growth rate for Revenue has been 3%. The projected CAGR for the next 3 years is 197%.